T1	Participants 761 773	416 patients
T2	Participants 53 93	patients with advanced renal cell cancer
T3	Participants 319 380	pre-treated patients with advanced renal cell carcinoma (RCC)
T4	Participants 1441 1479	pre-treated patients with advanced RCC
